Combination treatment for chronic HCV hepatitis in lymphangioleiomyomatosis: first case report

J Chemother. 2009 Feb;21(1):110-1. doi: 10.1179/joc.2009.21.1.110.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antiviral Agents / administration & dosage*
  • Female
  • Hepatitis C, Chronic / complications
  • Hepatitis C, Chronic / drug therapy*
  • Hepatitis C, Chronic / physiopathology
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / administration & dosage*
  • Lung Neoplasms / complications*
  • Lung Neoplasms / physiopathology
  • Lymphangioleiomyomatosis / complications*
  • Lymphangioleiomyomatosis / physiopathology
  • Polyethylene Glycols / administration & dosage*
  • Recombinant Proteins
  • Ribavirin / administration & dosage*

Substances

  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Polyethylene Glycols
  • Ribavirin
  • peginterferon alfa-2a